News & Perspective
Drugs & Diseases
CME & Education
Academy
Video
Decision Point
Edition: English

Medscape

English
Deutsch
Español
Français
Português
UKNew

Univadis

Sign Up It's Free!
English Edition

Medscape

Univadis

    X
    Univadis from Medscape

    No Results

      News & Perspective Drugs & Diseases CME & Education Academy Video Decision Point
      Close

      References

      1. Chen WH, et al. Single-dose live cholera vaccine CVD 103-HgR protects against human experimental infection with Vibrio cholerae 01 El Tor. Clin Infect Dis. 2016 Jun 1;62(11):1329-35.
      2. Foster GR, et al. Astral-2 and -3 Investigators. Sofosbuvir and velpatasvir for HCV genotypes 2 and 3 infection. N Engl J Med. 2015 Dec 31;373(27):2608-17.
      3. Feld JJ, et al. Astral-1 Investigators. Sofosbuvir and velpatasvir for HCV genotype 1, 2, 4, 5, and 6 infection. N Engl J Med. 2015 Dec 31;373(27):2599-607.
      4. Curry MP, et al. Astral-4 Investigators. Sofosbuvir and velpatasvir for HCV in patients with decompensated cirrhosis. N Engl J Med. 2015 Dec 31;373(27):2618-28.
      5. Giles TD, et al. Efficacy and safety of nebivolol and valsartan as fixed-dose combination in hypertension: a randomised, multicentre study. Lancet. 2014 May 31;383(9932):1889-98.
      6. Rayaldee (calcifediol) prescribing information. OPKO Pharmaceuticals, LCC. Miami, FL. June 2016. http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/208010s000lbl.pdf
      7. Brezin AP, et al. Adalimumab in patients with active, noninfectious uveitis using high-dose corticosteroids [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). http://acrabstracts.org/abstract/adalimumab-in-patients-with-active-noninfectious-uveitis-using-high-dose-corticosteroids/
      8. Nguyen QD, et al. Adalimumab in patients with inactive, non-infectious uveitis requiring systemic treatment [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). http://acrabstracts.org/abstract/adalimumab-in-patients-with-inactive-non-infectious-uveitis-requiring-systemic-treatment/
      9. Tivicay (dolutegravir) prescribing information. ViiV Healthcare. Research Triangle Park, NC. June 2016. http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/204790Orig1s008lbl.pdf
      10. Prezista (darunavir) prescribing information. Janssen Pharmaceuticals, Inc. Titusville, NJ. June 2016. http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/021976s043,202895s017lbledt.pdf
      11. CDC Newsroom. ACIP votes down use of LAIV for 2016-2017 flu season. June 22 2016. http://www.cdc.gov/media/releases/2016/s0622-laiv-flu.html
      12. Davlin SL, et al. Influenza Activity - United States, 2015-16 Season and Composition of the 2016-17 Influenza Vaccine. MMWR Morb Mortal Wkly Rep. 2016 Jun 10;65(22):567-75. http://www.cdc.gov/mmwr/volumes/65/wr/mm6522a3.htm?s_cid=mm6522a3_w
      13. GoNitro (sublingual nitroglycerin) prescribing information. Espero Pharmaceuticals, Inc. Jacksonville, FL. June, 2016. http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/208424s000lbl.pdf
      14. Orfadin (nitisinone) prescribing information. Swedish Orphan, Sweden. Marketed by Sobi, Inc. Waltham, MA. June 2016. http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/021232s017lbl.pdf
      Close

      Contributor Information

      Author

      Mary L Windle, PharmD
      Editor-in-Chief, Medscape Drug Reference

      Loading...

      EXIT FULLSCREEN

      .
      Find Us On
      About
      About Medscape Privacy Policy Editorial Policy Cookies Terms of Use Advertising Policy Help Center
      Membership
      Become a Member About You Professional Information Newsletters & Alerts Market Research
      App
      Medscape
      WebMD Network
      Medscape Live Events WebMD MedicineNet eMedicineHealth RxList WebMD Corporate Medscape UK
      Editions
      English Deutsch Español Français Português UK
      All material on this website is protected by copyright, Copyright © 1994-2023 by WebMD LLC. This website also contains material copyrighted by 3rd parties.